Atlas Trials

In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma

Clinical trial NCT02489266 · WITHDRAWN

Trial details

NCT number
NCT02489266
Sponsor
National Cancer Institute (NCI)
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Melanoma
Start date
2015-06-24
Primary completion
2016-06-29
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.